近日,复星国际(0656.HK,股价4.3港元,市值351.83亿港元)公布2024年度业绩,全年总收入为1921.4亿元,产业运营利润为49亿元。其中,四大核心子公司豫园股份、复星医药、复星葡萄牙保险和复星旅文的总收入达1346.5亿元,占集团总收入的70.1%。 集团当期亏损约43.5亿元,主要由于调整所投菜鸟项目的账面价值所致。剔除菜鸟项目因素影响,2024年度归母净利润约为7.5亿元。 ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.